plerixafor has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, A; Calandra, G; Cannon, RO; Childs, RW; Csako, G; McCoy, JP; Patibandla, S; Samsel, L; Smith, A; Zalos, G | 1 |
1 trial(s) available for plerixafor and Cardiovascular Diseases
| Article | Year |
|---|---|
Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease.
Topics: AC133 Antigen; Adult; Antigens, CD; Benzylamines; Blood Cell Count; Cardiovascular Diseases; Cyclams; Female; Flow Cytometry; Glycoproteins; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Peptides; Receptors, CXCR4 | 2009 |